Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemia

被引:16
作者
Bartley, Paul A. [1 ]
Martin-Harris, Michael H. [1 ]
Budgen, Bradley J. [1 ]
Ross, David M. [1 ,2 ]
Morley, Alexander A. [1 ,3 ]
机构
[1] Flinders Univ & Med Ctr, Dept Haematol & Genet Pathol, Bedford Pk, SA, Australia
[2] Inst Med & Vet Sci, Dept Haematol, Adelaide, SA 5000, Australia
[3] Monoquant PL, Adelaide, SA, Australia
关键词
chronic myeloid leukaemia; acute promyelocytic leukaemia; polymerase chain reaction; translocations; BCR-ABL1; PML-RARA; PCR; AMPLIFICATION; CDNA; DNA;
D O I
10.1111/j.1365-2141.2009.08071.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Isolation and sequencing of the translocation breakpoint in chronic myeloid leukaemia-(CML) and acute promyelocytic leukaemia (APML) may help to elucidate the mechanism of translocation and provide a molecular marker for monitoring of minimal residual disease. Amplification across the translocation breakpoint was performed in samples from 91 patients with CML and 15 patients with APML using single-tube multiplex polymerase chain reaction (PCR) involving 308 primers for CML and 40 primers for APML. Nonspecific amplification was removed by a modification of PCR, termed sequential hybrid primer PCR (SHP-PCR), which involved two sequential rounds of PCR, each of which used a low concentration of a specially designed hybrid primer. The resultant amplified material was sequenced. The method as finally developed was simple quick and robust. The translocation breakpoint was successfully isolated and sequenced in all 106 samples. The strategy of highly multiplexed PCR followed by SHP-PCR is thus an effective method for isolating the translocation breakpoint in CML and APML. It may also be applicable to other haematological disorders characterised by translocation, deletion or inversion.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 10 条
[1]   The elimination of primer-dimer accumulation in PCR [J].
Brownie, J ;
Shawcross, S ;
Theaker, J ;
Whitcombe, D ;
Ferrie, R ;
Newton, C ;
Little, S .
NUCLEIC ACIDS RESEARCH, 1997, 25 (16) :3235-3241
[2]  
Chenchik A, 1996, BIOTECHNIQUES, V21, P526
[3]   Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods [J].
Kantarjian, Hagop ;
Schiffer, Charles ;
Jones, Dan ;
Cortes, Jorge .
BLOOD, 2008, 111 (04) :1774-1780
[4]   Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia [J].
Mattarucchi, Elia ;
Guerini, Vittoria ;
Rambaldi, Alessandro ;
Campiotti, Leonardo ;
Venco, Achille ;
Pasquali, Francesco ;
Lo Curto, Francesco ;
Porta, Giovanni .
GENES CHROMOSOMES & CANCER, 2008, 47 (07) :625-632
[5]   Amplification of cDNA ends based on template-switching effect and step-out PCR [J].
Matz, M ;
Shagin, D ;
Bogdanova, E ;
Britanova, O ;
Lukyanov, S ;
Diatchenko, L ;
Chenchik, A .
NUCLEIC ACIDS RESEARCH, 1999, 27 (06) :1558-1560
[6]  
MORLEY AA, 2008, Patent No. 20081434841
[7]  
MORLEY AA, 2009, Patent No. 2009052547
[8]   AN IMPROVED PCR METHOD FOR WALKING IN UNCLONED GENOMIC DNA [J].
SIEBERT, PD ;
CHENCHIK, A ;
KELLOGG, DE ;
LUKYANOV, KA ;
LUKYANOV, SA .
NUCLEIC ACIDS RESEARCH, 1995, 23 (06) :1087-1088
[9]  
Waller CF, 1999, CLIN CANCER RES, V5, P4146
[10]   CHARACTERIZATION OF GENOMIC BCR-ABL BREAKPOINTS IN CHRONIC MYELOID-LEUKEMIA BY PCR [J].
ZHANG, JG ;
GOLDMAN, JM ;
CROSS, NCP .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (01) :138-146